Spectrum Pharmaceuticals, Inc. product portfolio
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Product Portfolio

Products

Spectrum and its subsidiaries have a diversified portfolio of proprietary drugs, including a number that address large markets, which could be transformative to the Company. These products are in various stages of development, with a focus on oncology/hematology. The Company also has six FDA-approved oncology/hematology products which help fund development of these potential products.

Click any area on the chart below to learn more on a specific drug .

Spectrum Pharmaceuticals, Inc. product portfolio

Back to top

Fusilev
PoziotinibPralatraxatePoziotinib Qapzola Apaziquone Pralatraxate Rolontis